The partnership will support MRI-guided delivery of investigational gene therapy EPY201 in first-in-human trials targeting focal refractory epilepsy, where precision administration is "key to efficacy and safety"
Artificial intelligence is rapidly transitioning from a technology pipedream to an operational reality for many businesses in the pharmaceutical and medical device...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.